• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll 样受体如何影响微生物群-肠-脑轴中的帕金森病。

How Toll-like receptors influence Parkinson's disease in the microbiome-gut-brain axis.

机构信息

Department of Anesthesiology, Baotou Central Hospital, Baotou, China.

Baotou Clinical Medical College, Inner Mongolia Medical University, Baotou, China.

出版信息

Front Immunol. 2023 May 3;14:1154626. doi: 10.3389/fimmu.2023.1154626. eCollection 2023.

DOI:10.3389/fimmu.2023.1154626
PMID:37207228
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10189046/
Abstract

Recently, a large number of experimenters have found that the pathogenesis of Parkinson's disease may be related to the gut microbiome and proposed the microbiome-gut-brain axis. Studies have shown that Toll-like receptors, especially Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4), are key mediators of gut homeostasis. In addition to their established role in innate immunity throughout the body, research is increasingly showing that the Toll-like receptor 2 and Toll-like receptor 4 signaling pathways shape the development and function of the gut and enteric nervous system. Notably, Toll-like receptor 2 and Toll-like receptor 4 are dysregulated in Parkinson's disease patients and may therefore be identified as the core of early gut dysfunction in Parkinson's disease. To better understand the contribution of Toll-like receptor 2 and Toll-like receptor 4 dysfunction in the gut to early α-synuclein aggregation, we discussed the structural function of Toll-like receptor 2 and Toll-like receptor 4 and signal transduction of Toll-like receptor 2 and Toll-like receptor 4 in Parkinson's disease by reviewing clinical, animal models, and studies. We also present a conceptual model of the pathogenesis of Parkinson's disease, in which microbial dysbiosis alters the gut barrier as well as the Toll-like receptor 2 and Toll-like receptor 4 signaling pathways, ultimately leading to a positive feedback loop for chronic gut dysfunction, promoting α-synuclein aggregation in the gut and vagus nerve.

摘要

最近,大量的实验人员发现帕金森病的发病机制可能与肠道微生物群有关,并提出了微生物群-肠道-大脑轴的概念。研究表明,Toll 样受体(TLR),特别是 TLR2 和 TLR4,是肠道内稳态的关键调节因子。除了在全身固有免疫中发挥已确立的作用外,研究越来越表明 TLR2 和 TLR4 信号通路塑造了肠道和肠神经系统的发育和功能。值得注意的是,TLR2 和 TLR4 在帕金森病患者中失调,因此可能被认为是帕金森病早期肠道功能障碍的核心。为了更好地了解 TLR2 和 TLR4 功能障碍在肠道对早期α-突触核蛋白聚集的贡献,我们通过回顾临床、动物模型和研究,讨论了 TLR2 和 TLR4 的结构功能以及 TLR2 和 TLR4 的信号转导在帕金森病中的作用。我们还提出了一个帕金森病发病机制的概念模型,其中微生物失调改变了肠道屏障以及 TLR2 和 TLR4 信号通路,最终导致慢性肠道功能障碍的正反馈循环,促进肠道和迷走神经中α-突触核蛋白的聚集。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b17/10189046/36810cf80ad8/fimmu-14-1154626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b17/10189046/36810cf80ad8/fimmu-14-1154626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b17/10189046/36810cf80ad8/fimmu-14-1154626-g001.jpg

相似文献

1
How Toll-like receptors influence Parkinson's disease in the microbiome-gut-brain axis.Toll 样受体如何影响微生物群-肠-脑轴中的帕金森病。
Front Immunol. 2023 May 3;14:1154626. doi: 10.3389/fimmu.2023.1154626. eCollection 2023.
2
TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut.TLR2 和 TLR4 在帕金森病发病机制中的作用:环境对肠道造成损害。
Transl Neurodegener. 2021 Nov 17;10(1):47. doi: 10.1186/s40035-021-00271-0.
3
Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.肠道微生物群-脑-肠轴与帕金森病中的 Toll 样受体
Int J Mol Sci. 2018 Jun 6;19(6):1689. doi: 10.3390/ijms19061689.
4
Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease.帕金森病患者及小鼠模型血液和大脑中Toll样受体的表达
Int J Neuropsychopharmacol. 2014 Dec 7;18(6):pyu103. doi: 10.1093/ijnp/pyu103.
5
The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.肠-脑轴:帕金森病中的双向信号传导
Cell Mol Neurobiol. 2022 Mar;42(2):315-332. doi: 10.1007/s10571-021-01066-7. Epub 2021 Mar 2.
6
Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathies.Toll 样受体及其在帕金森病和α-突触核蛋白病中的治疗潜力。
Brain Behav Immun. 2019 Oct;81:41-51. doi: 10.1016/j.bbi.2019.06.042. Epub 2019 Jul 2.
7
Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.Toll 样受体 2 在帕金森病大脑中的神经元中增加,可能导致α-突触核蛋白病理。
Acta Neuropathol. 2017 Feb;133(2):303-319. doi: 10.1007/s00401-016-1648-8. Epub 2016 Nov 25.
8
From the Gut to the Brain: The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson's Disease.从肠道到大脑:肠胶质细胞的作用及其在帕金森病发病机制中的参与
Int J Mol Sci. 2024 Jan 20;25(2):1294. doi: 10.3390/ijms25021294.
9
Comprehensive Review on Potential Signaling Pathways Involving the Transfer of α-Synuclein from the Gut to the Brain That Leads to Parkinson's Disease.涉及α-突触核蛋白从肠道向大脑转移导致帕金森病的潜在信号通路的综合综述。
ACS Chem Neurosci. 2023 Feb 15;14(4):590-602. doi: 10.1021/acschemneuro.2c00730. Epub 2023 Feb 1.
10
Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis.肠道神经胶质细胞和微生物群-肠-脑轴在帕金森病发病机制中的作用。
Ageing Res Rev. 2023 Feb;84:101812. doi: 10.1016/j.arr.2022.101812. Epub 2022 Nov 29.

引用本文的文献

1
Noncoding RNA (ncRNA)-mediated regulation of TLRs: critical regulator of inflammation in tumor microenvironment.非编码RNA(ncRNA)介导的Toll样受体(TLR)调控:肿瘤微环境中炎症的关键调节因子
Med Oncol. 2025 Mar 31;42(5):144. doi: 10.1007/s12032-025-02690-9.
2
Association of Toll-like Receptor 4 Gene Polymorphisms with Diabetes Type 2 Patients in the Palestinian Population.巴勒斯坦人群中Toll样受体4基因多态性与2型糖尿病患者的关联
Endocr Metab Immune Disord Drug Targets. 2025;25(9):675-681. doi: 10.2174/0118715303301789240826113528.
3
Analysis of mortality in Parkinson disease in China: Exploration of recent and future trends.

本文引用的文献

1
Interactions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation.SARS-CoV-2 N- 蛋白与 α- 突触核蛋白相互作用加速了淀粉样蛋白的形成。
ACS Chem Neurosci. 2022 Jan 5;13(1):143-150. doi: 10.1021/acschemneuro.1c00666. Epub 2021 Dec 3.
2
TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut.TLR2 和 TLR4 在帕金森病发病机制中的作用:环境对肠道造成损害。
Transl Neurodegener. 2021 Nov 17;10(1):47. doi: 10.1186/s40035-021-00271-0.
3
Microglial NLRP3 Inflammasome Activation upon TLR2 and TLR5 Ligation by Distinct α-Synuclein Assemblies.
中国帕金森病死亡率分析:近期及未来趋势探索
Aging Med (Milton). 2024 Aug 19;7(4):490-498. doi: 10.1002/agm2.12354. eCollection 2024 Aug.
4
Postbiotics as Molecules Targeting Cellular Events of Aging Brain-The Role in Pathogenesis, Prophylaxis and Treatment of Neurodegenerative Diseases.后生元作为靶向衰老大脑细胞事件的分子-在神经退行性疾病的发病机制、预防和治疗中的作用。
Nutrients. 2024 Jul 12;16(14):2244. doi: 10.3390/nu16142244.
5
From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson's Disease Treatment?从肠道到大脑:肠道菌群是帕金森病治疗的新模式吗?
Cells. 2024 Apr 30;13(9):770. doi: 10.3390/cells13090770.
6
Treatment of preterm brain injury via gut-microbiota-metabolite-brain axis.通过肠-微生物群-代谢物-脑轴治疗早产儿脑损伤。
CNS Neurosci Ther. 2024 Jan;30(1):e14556. doi: 10.1111/cns.14556. Epub 2023 Dec 18.
7
Enteric glia as a player of gut-brain interactions during Parkinson's disease.在帕金森病中,肠神经胶质细胞作为肠-脑相互作用的参与者。
Front Neurosci. 2023 Nov 1;17:1281710. doi: 10.3389/fnins.2023.1281710. eCollection 2023.
8
The role of toll-like receptors in orchestrating osteogenic differentiation of mesenchymal stromal cells and osteoimmunology.Toll样受体在协调间充质基质细胞的成骨分化和骨免疫学中的作用。
Front Cell Dev Biol. 2023 Oct 23;11:1277686. doi: 10.3389/fcell.2023.1277686. eCollection 2023.
小胶质细胞 NLRP3 炎性体在 TLR2 和 TLR5 被不同 α-突触核蛋白聚集物交联后的激活作用。
J Immunol. 2021 Oct 15;207(8):2143-2154. doi: 10.4049/jimmunol.2100035. Epub 2021 Sep 10.
4
Living with the enemy: from protein-misfolding pathologies we know, to those we want to know.与敌共存:从我们已知的蛋白质错误折叠疾病,到我们想要了解的疾病。
Ageing Res Rev. 2021 Sep;70:101391. doi: 10.1016/j.arr.2021.101391. Epub 2021 Jun 11.
5
Toll-like receptors in neuroinflammation, neurodegeneration, and alcohol-induced brain damage.神经炎症、神经退行性变和酒精性脑损伤中的 Toll 样受体。
IUBMB Life. 2021 Jul;73(7):900-915. doi: 10.1002/iub.2510. Epub 2021 Jun 4.
6
The Intersection of Parkinson's Disease, Viral Infections, and COVID-19.帕金森病、病毒感染与 COVID-19 的交集。
Mol Neurobiol. 2021 Sep;58(9):4477-4486. doi: 10.1007/s12035-021-02408-8. Epub 2021 May 25.
7
Onset of Skin, Gut, and Genitourinary Prodromal Parkinson's Disease: A Study of 1.5 Million Veterans.皮肤、肠道和泌尿生殖系统前驱期帕金森病的发病:一项涉及 150 万退伍军人的研究。
Mov Disord. 2021 Sep;36(9):2094-2103. doi: 10.1002/mds.28636. Epub 2021 May 3.
8
Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation.帕金森病肠道微生物群的荟萃分析表明,其改变与肠道炎症有关。
NPJ Parkinsons Dis. 2021 Mar 10;7(1):27. doi: 10.1038/s41531-021-00156-z.
9
Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.先天免疫受体刺激对脑驻留细胞摄取和降解细胞外α-突触核蛋白的影响。
Exp Mol Med. 2021 Feb;53(2):281-290. doi: 10.1038/s12276-021-00562-6. Epub 2021 Feb 16.
10
Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case-Control Study in an Australian Cohort.帕金森病胃肠道症状类型及严重程度的特征分析:澳大利亚队列的病例对照研究
Mov Disord Clin Pract. 2021 Jan 5;8(2):245-253. doi: 10.1002/mdc3.13134. eCollection 2021 Feb.